• Info
  • Insider Ownership

Insider Trading & Ownership of Stuart Poulton

Location
Newton, MA
Summary
The estimated net worth of Stuart Poulton is at least $887,579 dollars as of 03 Mar 2026. Stuart Poulton is the EVP, Chief Development Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $887.6K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stuart Poulton
All Insider Reports
All Insider Reports

Notify me when Stuart Poulton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Stuart Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. EVP, Chief Development Officer $887,579 -$54,673 -5.8% 02 Mar 2026

Insider Transactions Reported by Stuart Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.